Philips, a global leader in health technology, agreed to acquire Intact Vascular, a developer of medical devices for minimally-invasive peripheral vascular procedures, from private equity firms New Enterprise Associates, Quaker Partners, HIG BioVentures and Vensana Capital for $360m. "Acquiring Intact Vascular will expand our portfolio of minimally invasive therapy options for Peripheral Artery Disease with the Tack Endovascular System, a much needed implant that effectively restores blood flow in small limb vessels, promotes healing and preserves limbs," Chris Landon, Philips Senior Vice President and General Manager Image Guided Therapy Devices.